Over 6 million Americans are currently living with dementia Every three seconds, someone in the world develops dementia.

A new oral treatment is offering hope for people at risk of frontotemporal dementia (FTD), a serious brain disease that ...

A new study shows that lecanemab, an amyloid-clearing Alzheimer’s therapy, does not improve the brain’s waste-removal network ...

Morgan showed the video to her doctor, and following tests, Lydia was diagnosed with Sanfilippo syndrome B — often called ...

Researchers from DANDRITE have played a central role in developing a new oral treatment that, for the first time ever, has ...

A study published Wednesday reports "significant" disparities in the risk of dementia for lower income and non-white ...

Dr. Lauren Streicher, a professor of obstetrics and gynecology at Northwestern, has some reservations about federal health ...

Researchers from DANDRITE have played a central role in developing a new oral treatment that, for the first time ever, has shown promising results in a clinical trial involving patients – a ...

The investigational Bruton's tyrosine kinase inhibitor fenebrutinib reduced annualized relapse rates versus teriflunomide ...

The HHS has announced changes to estrogen hormone therapy black box labeling for menopause treatment in a move that they said corrects misleading warnings.HHS Secretary Robert F. Kennedy Jr. said in a ...

In a pivotal move, the US Food and Drug Administration has changed // done away with the lengthy black box warning on many hormone treatments for women with menopause symptoms.

The benefits of hormone replacement have been underappreciated, Dr. Marty Makary, the agency’s commissioner, said on Monday. Critics described evidence for the change as insufficient.